Researchers at Harvard University and the Wyss Institute are developing an injectable biomaterial that forms a tiny scaffold in the body which can be used to re-program cells and trigger an immune response to fight cancer and infectious diseases. Ben Gruber Reports.
02:20
02:28
02:40
01:23
01:55
01:26
02:38
01:49
02:02
01:44
01:12
02:06
01:50
01:43
02:03
01:04
02:03
01:48
02:59
01:47